<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="visit http://creativecommons.org/licenses/by/4.0/. Abstract Respiratory Syncytial Virus (RSV) can cause severe" exact="respiratory disease," post="yet a licensed vaccine is not available. We determined"/>
 <result pre="age of 65 are infected with RSV annually, leading to" exact="pneumonia" post="in 10–20% and death in 8% of those hospitalized"/>
 <result pre="obstacle of safety concerns raised after the occurrence of enhanced" exact="respiratory disease" post="(ERD) following natural RSV infection in RSV-naive infants that"/>
 <result pre="viral load, implying their capacity to protect against severe respiratory" exact="viral disease" post="when humoral immunity is insufficient.28 Based on these observations,"/>
 <result pre="under specific pathogen free conditions after screening negative for Mycobacterium" exact="tuberculosis" post="(by Mantoux test), for simian immunodeficiency virus, simian retrovirus,"/>
 <result pre="and polymerase chain reaction). Screening included Herpes B virus and" exact="measles" post="serology, but results were not included in the SPF"/>
 <result pre="based on the method described in ref. 61 A549 human" exact="lung carcinoma" post="cells (catalog number ATCC CCL-185, obtained from the American"/>
 <result pre="determined using a luciferase-based RSV VNA. Five thousand A549 human" exact="lung carcinoma" post="cells (catalog number ATCC CCL-185, obtained from the American"/>
 <result pre="elderly and high-risk adultsN. Engl. J. Med.20053521749175910.1056/NEJMoa04395115858184 6.HanLLAlexanderJPAndersonLJRespiratory syncytial virus" exact="pneumonia" post="among the elderly: an assessment of disease burdenJ. Infect."/>
 <result pre="assessment of disease burdenJ. Infect. Dis.1999179253010.1086/3145679841818 7.ThompsonWWet al.Mortality associated with" exact="influenza" post="and respiratory syncytial virus in the United StatesJAMA200328917918610.1001/jama.289.2.17912517228 8.PalivizumabAHumanized"/>
 <result pre="(rsv) vaccines–nonadjuvanted vaccine or vaccine adjuvanted with alum–given concomitantly with" exact="influenza" post="vaccine to high-risk elderly individualsJ. Infect. Dis.20081981317132610.1086/59216818855558 19.GroothuisJRet al.Prophylactic"/>
 <result pre="of a prime-boost vaccine schedule with distinct adenovirus vectors against" exact="malaria" post="in rhesus monkeysVaccine2009276226623310.1016/j.vaccine.2009.07.10619686691 34.HoftDFet al.A recombinant adenovirus expressing immunodominant"/>
 <result pre="reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite" exact="malaria" post="vaccine in Burkinabe healthy adults 18 to 45 years"/>
 <result pre="in healthy adults (IPCAVD 001)J. Infect. Dis.201320724825610.1093/infdis/jis67123125443 37.AbelBet al.The novel" exact="tuberculosis" post="vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+"/>
 <result pre="of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated" exact="hypersensitivity" post="to subsequent RSV infectionJ. Virol.200276115611156910.1128/JVI.76.22.11561-11569.200212388717 43.MagroMet al.Neutralizing antibodies against"/>
 <result pre="immunogenicity to Plasmodium falciparum CS compared to that with either" exact="malaria" post="vaccine aloneInfect. Immun.2007752283229010.1128/IAI.01879-0617307942 56.KakukTJet al.A human respiratory syncytial virus"/>
</results>
